Abbott Laboratories Faces Whistleblower Lawsuit Concerning Depakote
Off-label use is the practice of prescribing pharmaceuticals for an unapproved indication or in an unapproved age group, unapproved dose or unapproved form of administration. In the United States, the Food and Drug Administration Center for Drug Evaluation and Research (CDER) reviews a company’s New Drug Application (NDA) for data from clinical trials to see […]
